nodes	percent_of_prediction	percent_of_DWPC	metapath
Telithromycin—CYP3A4—bone cancer	0.818	1	CbGaD
Telithromycin—Roxithromycin—CYP3A4—bone cancer	0.00189	0.292	CrCbGaD
Telithromycin—Azithromycin—CYP3A4—bone cancer	0.00189	0.292	CrCbGaD
Telithromycin—Clarithromycin—CYP3A4—bone cancer	0.00143	0.221	CrCbGaD
Telithromycin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00128	0.0872	CbGpPWpGaD
Telithromycin—Erythromycin—CYP3A4—bone cancer	0.00126	0.195	CrCbGaD
Telithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000963	0.0658	CbGpPWpGaD
Telithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000696	0.0475	CbGpPWpGaD
Telithromycin—Anaemia—Cisplatin—bone cancer	0.000549	0.00342	CcSEcCtD
Telithromycin—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000539	0.00335	CcSEcCtD
Telithromycin—Hepatic function abnormal—Doxorubicin—bone cancer	0.000536	0.00334	CcSEcCtD
Telithromycin—Leukopenia—Cisplatin—bone cancer	0.000532	0.00331	CcSEcCtD
Telithromycin—Hepatic failure—Doxorubicin—bone cancer	0.000521	0.00325	CcSEcCtD
Telithromycin—Eczema—Doxorubicin—bone cancer	0.000521	0.00325	CcSEcCtD
Telithromycin—Diplopia—Epirubicin—bone cancer	0.000506	0.00315	CcSEcCtD
Telithromycin—Myalgia—Cisplatin—bone cancer	0.000506	0.00315	CcSEcCtD
Telithromycin—Anxiety—Cisplatin—bone cancer	0.000504	0.00314	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000502	0.00313	CcSEcCtD
Telithromycin—Liver function test abnormal—Methotrexate—bone cancer	0.0005	0.00311	CcSEcCtD
Telithromycin—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000497	0.034	CbGpPWpGaD
Telithromycin—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000495	0.0338	CbGpPWpGaD
Telithromycin—Breast disorder—Methotrexate—bone cancer	0.000489	0.00304	CcSEcCtD
Telithromycin—Face oedema—Epirubicin—bone cancer	0.000489	0.00304	CcSEcCtD
Telithromycin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000487	0.00303	CcSEcCtD
Telithromycin—Anaphylactic shock—Cisplatin—bone cancer	0.000485	0.00302	CcSEcCtD
Telithromycin—Nervous system disorder—Cisplatin—bone cancer	0.000475	0.00296	CcSEcCtD
Telithromycin—Skin disorder—Cisplatin—bone cancer	0.000471	0.00293	CcSEcCtD
Telithromycin—Diplopia—Doxorubicin—bone cancer	0.000469	0.00292	CcSEcCtD
Telithromycin—Hyperhidrosis—Cisplatin—bone cancer	0.000469	0.00292	CcSEcCtD
Telithromycin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000468	0.032	CbGpPWpGaD
Telithromycin—Liver function test abnormal—Epirubicin—bone cancer	0.000468	0.00291	CcSEcCtD
Telithromycin—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000465	0.0317	CbGpPWpGaD
Telithromycin—Eosinophilia—Methotrexate—bone cancer	0.000463	0.00288	CcSEcCtD
Telithromycin—Abdominal pain upper—Epirubicin—bone cancer	0.000463	0.00288	CcSEcCtD
Telithromycin—Anorexia—Cisplatin—bone cancer	0.000462	0.00288	CcSEcCtD
Telithromycin—Hypokalaemia—Epirubicin—bone cancer	0.000461	0.00287	CcSEcCtD
Telithromycin—Pancreatitis—Methotrexate—bone cancer	0.000459	0.00286	CcSEcCtD
Telithromycin—Breast disorder—Epirubicin—bone cancer	0.000458	0.00285	CcSEcCtD
Telithromycin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000456	0.00284	CcSEcCtD
Telithromycin—Hypotension—Cisplatin—bone cancer	0.000453	0.00282	CcSEcCtD
Telithromycin—Face oedema—Doxorubicin—bone cancer	0.000452	0.00282	CcSEcCtD
Telithromycin—Abdominal discomfort—Methotrexate—bone cancer	0.000448	0.00279	CcSEcCtD
Telithromycin—Gastritis—Epirubicin—bone cancer	0.000448	0.00279	CcSEcCtD
Telithromycin—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000447	0.0305	CbGpPWpGaD
Telithromycin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000442	0.00275	CcSEcCtD
Telithromycin—Abdominal distension—Epirubicin—bone cancer	0.000441	0.00274	CcSEcCtD
Telithromycin—Neutropenia—Methotrexate—bone cancer	0.000437	0.00272	CcSEcCtD
Telithromycin—Paraesthesia—Cisplatin—bone cancer	0.000435	0.00271	CcSEcCtD
Telithromycin—Eosinophilia—Epirubicin—bone cancer	0.000433	0.0027	CcSEcCtD
Telithromycin—Liver function test abnormal—Doxorubicin—bone cancer	0.000433	0.00269	CcSEcCtD
Telithromycin—Pancreatitis—Epirubicin—bone cancer	0.000429	0.00267	CcSEcCtD
Telithromycin—Abdominal pain upper—Doxorubicin—bone cancer	0.000428	0.00266	CcSEcCtD
Telithromycin—Hypokalaemia—Doxorubicin—bone cancer	0.000426	0.00266	CcSEcCtD
Telithromycin—Breast disorder—Doxorubicin—bone cancer	0.000423	0.00264	CcSEcCtD
Telithromycin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000422	0.00263	CcSEcCtD
Telithromycin—Decreased appetite—Cisplatin—bone cancer	0.000421	0.00262	CcSEcCtD
Telithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000419	0.0286	CbGpPWpGaD
Telithromycin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000418	0.00261	CcSEcCtD
Telithromycin—Infestation—Methotrexate—bone cancer	0.000417	0.0026	CcSEcCtD
Telithromycin—Infestation NOS—Methotrexate—bone cancer	0.000417	0.0026	CcSEcCtD
Telithromycin—Gastritis—Doxorubicin—bone cancer	0.000415	0.00258	CcSEcCtD
Telithromycin—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000414	0.0283	CbGpPWpGaD
Telithromycin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000413	0.00257	CcSEcCtD
Telithromycin—Neutropenia—Epirubicin—bone cancer	0.000409	0.00255	CcSEcCtD
Telithromycin—Abdominal distension—Doxorubicin—bone cancer	0.000408	0.00254	CcSEcCtD
Telithromycin—Stomatitis—Methotrexate—bone cancer	0.000407	0.00253	CcSEcCtD
Telithromycin—Eosinophilia—Doxorubicin—bone cancer	0.000401	0.0025	CcSEcCtD
Telithromycin—Feeling abnormal—Cisplatin—bone cancer	0.000399	0.00249	CcSEcCtD
Telithromycin—Pancreatitis—Doxorubicin—bone cancer	0.000397	0.00247	CcSEcCtD
Telithromycin—Hepatobiliary disease—Methotrexate—bone cancer	0.000394	0.00246	CcSEcCtD
Telithromycin—Infestation—Epirubicin—bone cancer	0.00039	0.00243	CcSEcCtD
Telithromycin—Infestation NOS—Epirubicin—bone cancer	0.00039	0.00243	CcSEcCtD
Telithromycin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000387	0.00241	CcSEcCtD
Telithromycin—Stomatitis—Epirubicin—bone cancer	0.00038	0.00237	CcSEcCtD
Telithromycin—Jaundice—Epirubicin—bone cancer	0.00038	0.00237	CcSEcCtD
Telithromycin—Neutropenia—Doxorubicin—bone cancer	0.000379	0.00236	CcSEcCtD
Telithromycin—Hepatitis—Methotrexate—bone cancer	0.000374	0.00233	CcSEcCtD
Telithromycin—Hepatobiliary disease—Epirubicin—bone cancer	0.000369	0.0023	CcSEcCtD
Telithromycin—Sinusitis—Epirubicin—bone cancer	0.000366	0.00228	CcSEcCtD
Telithromycin—Infestation—Doxorubicin—bone cancer	0.000361	0.00225	CcSEcCtD
Telithromycin—Infestation NOS—Doxorubicin—bone cancer	0.000361	0.00225	CcSEcCtD
Telithromycin—Visual impairment—Methotrexate—bone cancer	0.000361	0.00225	CcSEcCtD
Telithromycin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000358	0.00223	CcSEcCtD
Telithromycin—Hypersensitivity—Cisplatin—bone cancer	0.000357	0.00222	CcSEcCtD
Telithromycin—Bradycardia—Epirubicin—bone cancer	0.000357	0.00222	CcSEcCtD
Telithromycin—Erythema multiforme—Methotrexate—bone cancer	0.000354	0.0022	CcSEcCtD
Telithromycin—Stomatitis—Doxorubicin—bone cancer	0.000352	0.00219	CcSEcCtD
Telithromycin—Jaundice—Doxorubicin—bone cancer	0.000352	0.00219	CcSEcCtD
Telithromycin—Hepatitis—Epirubicin—bone cancer	0.00035	0.00218	CcSEcCtD
Telithromycin—Eye disorder—Methotrexate—bone cancer	0.00035	0.00218	CcSEcCtD
Telithromycin—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.00035	0.0239	CbGpPWpGaD
Telithromycin—Asthenia—Cisplatin—bone cancer	0.000348	0.00217	CcSEcCtD
Telithromycin—Cardiac disorder—Methotrexate—bone cancer	0.000347	0.00216	CcSEcCtD
Telithromycin—Oedema peripheral—Epirubicin—bone cancer	0.000345	0.00215	CcSEcCtD
Telithromycin—Connective tissue disorder—Epirubicin—bone cancer	0.000344	0.00214	CcSEcCtD
Telithromycin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000342	0.00213	CcSEcCtD
Telithromycin—Angiopathy—Methotrexate—bone cancer	0.00034	0.00211	CcSEcCtD
Telithromycin—Sinusitis—Doxorubicin—bone cancer	0.000339	0.00211	CcSEcCtD
Telithromycin—Immune system disorder—Methotrexate—bone cancer	0.000338	0.00211	CcSEcCtD
Telithromycin—Visual impairment—Epirubicin—bone cancer	0.000338	0.0021	CcSEcCtD
Telithromycin—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000336	0.0229	CbGpPWpGaD
Telithromycin—Diarrhoea—Cisplatin—bone cancer	0.000332	0.00206	CcSEcCtD
Telithromycin—Erythema multiforme—Epirubicin—bone cancer	0.000331	0.00206	CcSEcCtD
Telithromycin—Bradycardia—Doxorubicin—bone cancer	0.00033	0.00205	CcSEcCtD
Telithromycin—Mental disorder—Methotrexate—bone cancer	0.000328	0.00204	CcSEcCtD
Telithromycin—Eye disorder—Epirubicin—bone cancer	0.000327	0.00204	CcSEcCtD
Telithromycin—Malnutrition—Methotrexate—bone cancer	0.000326	0.00203	CcSEcCtD
Telithromycin—Flushing—Epirubicin—bone cancer	0.000325	0.00202	CcSEcCtD
Telithromycin—Cardiac disorder—Epirubicin—bone cancer	0.000325	0.00202	CcSEcCtD
Telithromycin—Hepatitis—Doxorubicin—bone cancer	0.000324	0.00202	CcSEcCtD
Telithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000323	0.0221	CbGpPWpGaD
Telithromycin—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000323	0.0221	CbGpPWpGaD
Telithromycin—Oedema peripheral—Doxorubicin—bone cancer	0.000319	0.00199	CcSEcCtD
Telithromycin—Dysgeusia—Methotrexate—bone cancer	0.000319	0.00199	CcSEcCtD
Telithromycin—Connective tissue disorder—Doxorubicin—bone cancer	0.000319	0.00198	CcSEcCtD
Telithromycin—Angiopathy—Epirubicin—bone cancer	0.000318	0.00198	CcSEcCtD
Telithromycin—Immune system disorder—Epirubicin—bone cancer	0.000316	0.00197	CcSEcCtD
Telithromycin—Back pain—Methotrexate—bone cancer	0.000315	0.00196	CcSEcCtD
Telithromycin—Arrhythmia—Epirubicin—bone cancer	0.000313	0.00195	CcSEcCtD
Telithromycin—Visual impairment—Doxorubicin—bone cancer	0.000312	0.00195	CcSEcCtD
Telithromycin—Vomiting—Cisplatin—bone cancer	0.000308	0.00192	CcSEcCtD
Telithromycin—Vision blurred—Methotrexate—bone cancer	0.000307	0.00191	CcSEcCtD
Telithromycin—Mental disorder—Epirubicin—bone cancer	0.000307	0.00191	CcSEcCtD
Telithromycin—Erythema multiforme—Doxorubicin—bone cancer	0.000307	0.00191	CcSEcCtD
Telithromycin—Rash—Cisplatin—bone cancer	0.000306	0.0019	CcSEcCtD
Telithromycin—Dermatitis—Cisplatin—bone cancer	0.000305	0.0019	CcSEcCtD
Telithromycin—Malnutrition—Epirubicin—bone cancer	0.000305	0.0019	CcSEcCtD
Telithromycin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000304	0.0208	CbGpPWpGaD
Telithromycin—Eye disorder—Doxorubicin—bone cancer	0.000303	0.00189	CcSEcCtD
Telithromycin—Anaemia—Methotrexate—bone cancer	0.000301	0.00188	CcSEcCtD
Telithromycin—Cardiac disorder—Doxorubicin—bone cancer	0.000301	0.00187	CcSEcCtD
Telithromycin—Flushing—Doxorubicin—bone cancer	0.000301	0.00187	CcSEcCtD
Telithromycin—Flatulence—Epirubicin—bone cancer	0.000301	0.00187	CcSEcCtD
Telithromycin—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000299	0.0205	CbGpPWpGaD
Telithromycin—Tension—Epirubicin—bone cancer	0.000299	0.00186	CcSEcCtD
Telithromycin—Dysgeusia—Epirubicin—bone cancer	0.000299	0.00186	CcSEcCtD
Telithromycin—Nervousness—Epirubicin—bone cancer	0.000296	0.00184	CcSEcCtD
Telithromycin—Back pain—Epirubicin—bone cancer	0.000295	0.00184	CcSEcCtD
Telithromycin—Angiopathy—Doxorubicin—bone cancer	0.000294	0.00183	CcSEcCtD
Telithromycin—Muscle spasms—Epirubicin—bone cancer	0.000293	0.00183	CcSEcCtD
Telithromycin—Immune system disorder—Doxorubicin—bone cancer	0.000293	0.00182	CcSEcCtD
Telithromycin—Vertigo—Methotrexate—bone cancer	0.000293	0.00182	CcSEcCtD
Telithromycin—Leukopenia—Methotrexate—bone cancer	0.000292	0.00182	CcSEcCtD
Telithromycin—Arrhythmia—Doxorubicin—bone cancer	0.00029	0.0018	CcSEcCtD
Telithromycin—Nausea—Cisplatin—bone cancer	0.000288	0.00179	CcSEcCtD
Telithromycin—Vision blurred—Epirubicin—bone cancer	0.000287	0.00179	CcSEcCtD
Telithromycin—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000285	0.0195	CbGpPWpGaD
Telithromycin—Mental disorder—Doxorubicin—bone cancer	0.000284	0.00177	CcSEcCtD
Telithromycin—Malnutrition—Doxorubicin—bone cancer	0.000282	0.00176	CcSEcCtD
Telithromycin—Anaemia—Epirubicin—bone cancer	0.000282	0.00176	CcSEcCtD
Telithromycin—Flatulence—Doxorubicin—bone cancer	0.000278	0.00173	CcSEcCtD
Telithromycin—Arthralgia—Methotrexate—bone cancer	0.000277	0.00173	CcSEcCtD
Telithromycin—Myalgia—Methotrexate—bone cancer	0.000277	0.00173	CcSEcCtD
Telithromycin—Tension—Doxorubicin—bone cancer	0.000277	0.00172	CcSEcCtD
Telithromycin—Dysgeusia—Doxorubicin—bone cancer	0.000276	0.00172	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000276	0.00172	CcSEcCtD
Telithromycin—Nervousness—Doxorubicin—bone cancer	0.000274	0.00171	CcSEcCtD
Telithromycin—Vertigo—Epirubicin—bone cancer	0.000274	0.00171	CcSEcCtD
Telithromycin—Syncope—Epirubicin—bone cancer	0.000274	0.0017	CcSEcCtD
Telithromycin—Leukopenia—Epirubicin—bone cancer	0.000273	0.0017	CcSEcCtD
Telithromycin—Back pain—Doxorubicin—bone cancer	0.000273	0.0017	CcSEcCtD
Telithromycin—Muscle spasms—Doxorubicin—bone cancer	0.000271	0.00169	CcSEcCtD
Telithromycin—Palpitations—Epirubicin—bone cancer	0.00027	0.00168	CcSEcCtD
Telithromycin—Confusional state—Methotrexate—bone cancer	0.000268	0.00167	CcSEcCtD
Telithromycin—Loss of consciousness—Epirubicin—bone cancer	0.000268	0.00167	CcSEcCtD
Telithromycin—Anaphylactic shock—Methotrexate—bone cancer	0.000266	0.00166	CcSEcCtD
Telithromycin—Vision blurred—Doxorubicin—bone cancer	0.000266	0.00166	CcSEcCtD
Telithromycin—Nervous system disorder—Methotrexate—bone cancer	0.000261	0.00162	CcSEcCtD
Telithromycin—Anaemia—Doxorubicin—bone cancer	0.000261	0.00162	CcSEcCtD
Telithromycin—Arthralgia—Epirubicin—bone cancer	0.00026	0.00162	CcSEcCtD
Telithromycin—Myalgia—Epirubicin—bone cancer	0.00026	0.00162	CcSEcCtD
Telithromycin—Anxiety—Epirubicin—bone cancer	0.000259	0.00161	CcSEcCtD
Telithromycin—Skin disorder—Methotrexate—bone cancer	0.000258	0.00161	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000258	0.00161	CcSEcCtD
Telithromycin—Hyperhidrosis—Methotrexate—bone cancer	0.000257	0.0016	CcSEcCtD
Telithromycin—Dry mouth—Epirubicin—bone cancer	0.000254	0.00158	CcSEcCtD
Telithromycin—Vertigo—Doxorubicin—bone cancer	0.000254	0.00158	CcSEcCtD
Telithromycin—Anorexia—Methotrexate—bone cancer	0.000254	0.00158	CcSEcCtD
Telithromycin—Syncope—Doxorubicin—bone cancer	0.000253	0.00158	CcSEcCtD
Telithromycin—Leukopenia—Doxorubicin—bone cancer	0.000253	0.00157	CcSEcCtD
Telithromycin—Confusional state—Epirubicin—bone cancer	0.000251	0.00156	CcSEcCtD
Telithromycin—Palpitations—Doxorubicin—bone cancer	0.000249	0.00155	CcSEcCtD
Telithromycin—Anaphylactic shock—Epirubicin—bone cancer	0.000249	0.00155	CcSEcCtD
Telithromycin—Hypotension—Methotrexate—bone cancer	0.000249	0.00155	CcSEcCtD
Telithromycin—Loss of consciousness—Doxorubicin—bone cancer	0.000248	0.00154	CcSEcCtD
Telithromycin—Shock—Epirubicin—bone cancer	0.000245	0.00152	CcSEcCtD
Telithromycin—Nervous system disorder—Epirubicin—bone cancer	0.000244	0.00152	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000242	0.00151	CcSEcCtD
Telithromycin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000242	0.0165	CbGpPWpGaD
Telithromycin—Skin disorder—Epirubicin—bone cancer	0.000242	0.00151	CcSEcCtD
Telithromycin—Hyperhidrosis—Epirubicin—bone cancer	0.000241	0.0015	CcSEcCtD
Telithromycin—Insomnia—Methotrexate—bone cancer	0.000241	0.0015	CcSEcCtD
Telithromycin—Myalgia—Doxorubicin—bone cancer	0.00024	0.0015	CcSEcCtD
Telithromycin—Arthralgia—Doxorubicin—bone cancer	0.00024	0.0015	CcSEcCtD
Telithromycin—Anxiety—Doxorubicin—bone cancer	0.000239	0.00149	CcSEcCtD
Telithromycin—Paraesthesia—Methotrexate—bone cancer	0.000239	0.00149	CcSEcCtD
Telithromycin—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000239	0.0163	CbGpPWpGaD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000239	0.00149	CcSEcCtD
Telithromycin—Anorexia—Epirubicin—bone cancer	0.000237	0.00148	CcSEcCtD
Telithromycin—Somnolence—Methotrexate—bone cancer	0.000236	0.00147	CcSEcCtD
Telithromycin—Dry mouth—Doxorubicin—bone cancer	0.000235	0.00146	CcSEcCtD
Telithromycin—Dyspepsia—Methotrexate—bone cancer	0.000234	0.00146	CcSEcCtD
Telithromycin—Hypotension—Epirubicin—bone cancer	0.000233	0.00145	CcSEcCtD
Telithromycin—Confusional state—Doxorubicin—bone cancer	0.000232	0.00145	CcSEcCtD
Telithromycin—Decreased appetite—Methotrexate—bone cancer	0.000231	0.00144	CcSEcCtD
Telithromycin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000231	0.0158	CbGpPWpGaD
Telithromycin—Anaphylactic shock—Doxorubicin—bone cancer	0.00023	0.00143	CcSEcCtD
Telithromycin—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00023	0.0157	CbGpPWpGaD
Telithromycin—Gastrointestinal disorder—Methotrexate—bone cancer	0.00023	0.00143	CcSEcCtD
Telithromycin—Fatigue—Methotrexate—bone cancer	0.000229	0.00143	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000227	0.00141	CcSEcCtD
Telithromycin—Shock—Doxorubicin—bone cancer	0.000227	0.00141	CcSEcCtD
Telithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000226	0.0155	CbGpPWpGaD
Telithromycin—Nervous system disorder—Doxorubicin—bone cancer	0.000226	0.00141	CcSEcCtD
Telithromycin—Insomnia—Epirubicin—bone cancer	0.000225	0.0014	CcSEcCtD
Telithromycin—Skin disorder—Doxorubicin—bone cancer	0.000224	0.00139	CcSEcCtD
Telithromycin—Paraesthesia—Epirubicin—bone cancer	0.000224	0.00139	CcSEcCtD
Telithromycin—Hyperhidrosis—Doxorubicin—bone cancer	0.000223	0.00139	CcSEcCtD
Telithromycin—Somnolence—Epirubicin—bone cancer	0.000221	0.00138	CcSEcCtD
Telithromycin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.00022	0.015	CbGpPWpGaD
Telithromycin—Anorexia—Doxorubicin—bone cancer	0.00022	0.00137	CcSEcCtD
Telithromycin—Feeling abnormal—Methotrexate—bone cancer	0.000219	0.00136	CcSEcCtD
Telithromycin—Dyspepsia—Epirubicin—bone cancer	0.000219	0.00136	CcSEcCtD
Telithromycin—Gastrointestinal pain—Methotrexate—bone cancer	0.000218	0.00135	CcSEcCtD
Telithromycin—Decreased appetite—Epirubicin—bone cancer	0.000216	0.00135	CcSEcCtD
Telithromycin—Hypotension—Doxorubicin—bone cancer	0.000215	0.00134	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000215	0.00134	CcSEcCtD
Telithromycin—Fatigue—Epirubicin—bone cancer	0.000215	0.00134	CcSEcCtD
Telithromycin—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000213	0.0146	CbGpPWpGaD
Telithromycin—Constipation—Epirubicin—bone cancer	0.000213	0.00133	CcSEcCtD
Telithromycin—Urticaria—Methotrexate—bone cancer	0.000211	0.00132	CcSEcCtD
Telithromycin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000211	0.0144	CbGpPWpGaD
Telithromycin—Abdominal pain—Methotrexate—bone cancer	0.00021	0.00131	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00021	0.00131	CcSEcCtD
Telithromycin—Insomnia—Doxorubicin—bone cancer	0.000208	0.0013	CcSEcCtD
Telithromycin—Paraesthesia—Doxorubicin—bone cancer	0.000207	0.00129	CcSEcCtD
Telithromycin—Feeling abnormal—Epirubicin—bone cancer	0.000205	0.00128	CcSEcCtD
Telithromycin—Somnolence—Doxorubicin—bone cancer	0.000205	0.00127	CcSEcCtD
Telithromycin—Gastrointestinal pain—Epirubicin—bone cancer	0.000204	0.00127	CcSEcCtD
Telithromycin—Dyspepsia—Doxorubicin—bone cancer	0.000203	0.00126	CcSEcCtD
Telithromycin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000202	0.0138	CbGpPWpGaD
Telithromycin—Decreased appetite—Doxorubicin—bone cancer	0.0002	0.00125	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000199	0.00124	CcSEcCtD
Telithromycin—Fatigue—Doxorubicin—bone cancer	0.000199	0.00124	CcSEcCtD
Telithromycin—Urticaria—Epirubicin—bone cancer	0.000198	0.00123	CcSEcCtD
Telithromycin—Constipation—Doxorubicin—bone cancer	0.000197	0.00123	CcSEcCtD
Telithromycin—Abdominal pain—Epirubicin—bone cancer	0.000197	0.00123	CcSEcCtD
Telithromycin—Hypersensitivity—Methotrexate—bone cancer	0.000196	0.00122	CcSEcCtD
Telithromycin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000195	0.0133	CbGpPWpGaD
Telithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000193	0.0132	CbGpPWpGaD
Telithromycin—Asthenia—Methotrexate—bone cancer	0.000191	0.00119	CcSEcCtD
Telithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00019	0.013	CbGpPWpGaD
Telithromycin—Feeling abnormal—Doxorubicin—bone cancer	0.00019	0.00118	CcSEcCtD
Telithromycin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000188	0.00117	CcSEcCtD
Telithromycin—Pruritus—Methotrexate—bone cancer	0.000188	0.00117	CcSEcCtD
Telithromycin—Hypersensitivity—Epirubicin—bone cancer	0.000183	0.00114	CcSEcCtD
Telithromycin—Urticaria—Doxorubicin—bone cancer	0.000183	0.00114	CcSEcCtD
Telithromycin—Abdominal pain—Doxorubicin—bone cancer	0.000182	0.00113	CcSEcCtD
Telithromycin—Diarrhoea—Methotrexate—bone cancer	0.000182	0.00113	CcSEcCtD
Telithromycin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.00018	0.0123	CbGpPWpGaD
Telithromycin—Asthenia—Epirubicin—bone cancer	0.000179	0.00111	CcSEcCtD
Telithromycin—Pruritus—Epirubicin—bone cancer	0.000176	0.0011	CcSEcCtD
Telithromycin—Dizziness—Methotrexate—bone cancer	0.000176	0.0011	CcSEcCtD
Telithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000175	0.0119	CbGpPWpGaD
Telithromycin—Diarrhoea—Epirubicin—bone cancer	0.00017	0.00106	CcSEcCtD
Telithromycin—Hypersensitivity—Doxorubicin—bone cancer	0.00017	0.00106	CcSEcCtD
Telithromycin—Vomiting—Methotrexate—bone cancer	0.000169	0.00105	CcSEcCtD
Telithromycin—Rash—Methotrexate—bone cancer	0.000168	0.00104	CcSEcCtD
Telithromycin—Dermatitis—Methotrexate—bone cancer	0.000168	0.00104	CcSEcCtD
Telithromycin—Headache—Methotrexate—bone cancer	0.000167	0.00104	CcSEcCtD
Telithromycin—Asthenia—Doxorubicin—bone cancer	0.000165	0.00103	CcSEcCtD
Telithromycin—Dizziness—Epirubicin—bone cancer	0.000165	0.00102	CcSEcCtD
Telithromycin—Pruritus—Doxorubicin—bone cancer	0.000163	0.00101	CcSEcCtD
Telithromycin—Vomiting—Epirubicin—bone cancer	0.000158	0.000985	CcSEcCtD
Telithromycin—Nausea—Methotrexate—bone cancer	0.000158	0.000984	CcSEcCtD
Telithromycin—Diarrhoea—Doxorubicin—bone cancer	0.000158	0.000981	CcSEcCtD
Telithromycin—Rash—Epirubicin—bone cancer	0.000157	0.000977	CcSEcCtD
Telithromycin—Dermatitis—Epirubicin—bone cancer	0.000157	0.000976	CcSEcCtD
Telithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000156	0.0107	CbGpPWpGaD
Telithromycin—Headache—Epirubicin—bone cancer	0.000156	0.000971	CcSEcCtD
Telithromycin—Dizziness—Doxorubicin—bone cancer	0.000152	0.000948	CcSEcCtD
Telithromycin—Nausea—Epirubicin—bone cancer	0.000148	0.000921	CcSEcCtD
Telithromycin—Vomiting—Doxorubicin—bone cancer	0.000146	0.000912	CcSEcCtD
Telithromycin—Rash—Doxorubicin—bone cancer	0.000145	0.000904	CcSEcCtD
Telithromycin—Dermatitis—Doxorubicin—bone cancer	0.000145	0.000903	CcSEcCtD
Telithromycin—Headache—Doxorubicin—bone cancer	0.000144	0.000898	CcSEcCtD
Telithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000139	0.00953	CbGpPWpGaD
Telithromycin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000139	0.00951	CbGpPWpGaD
Telithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000138	0.0094	CbGpPWpGaD
Telithromycin—Nausea—Doxorubicin—bone cancer	0.000137	0.000852	CcSEcCtD
Telithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000132	0.00904	CbGpPWpGaD
Telithromycin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000114	0.00779	CbGpPWpGaD
Telithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000113	0.00772	CbGpPWpGaD
Telithromycin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000104	0.0071	CbGpPWpGaD
Telithromycin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	9.91e-05	0.00678	CbGpPWpGaD
Telithromycin—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	9.78e-05	0.00669	CbGpPWpGaD
Telithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.4e-05	0.00574	CbGpPWpGaD
Telithromycin—CYP3A7—Biological oxidations—CYP3A4—bone cancer	8.31e-05	0.00568	CbGpPWpGaD
Telithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.29e-05	0.00566	CbGpPWpGaD
Telithromycin—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	8.19e-05	0.0056	CbGpPWpGaD
Telithromycin—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.04e-05	0.00549	CbGpPWpGaD
Telithromycin—CYP3A7—Biological oxidations—GSTP1—bone cancer	7.1e-05	0.00485	CbGpPWpGaD
Telithromycin—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	7.01e-05	0.00479	CbGpPWpGaD
Telithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.81e-05	0.00465	CbGpPWpGaD
Telithromycin—CYP3A5—Biological oxidations—CYP3A4—bone cancer	6e-05	0.0041	CbGpPWpGaD
Telithromycin—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	5.92e-05	0.00405	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	5.6e-05	0.00383	CbGpPWpGaD
Telithromycin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	5.29e-05	0.00361	CbGpPWpGaD
Telithromycin—CYP3A5—Biological oxidations—GSTP1—bone cancer	5.14e-05	0.00351	CbGpPWpGaD
Telithromycin—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	5.06e-05	0.00346	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—NDUFA12—bone cancer	4.98e-05	0.0034	CbGpPWpGaD
Telithromycin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	4.77e-05	0.00326	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	4.6e-05	0.00315	CbGpPWpGaD
Telithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	4.31e-05	0.00294	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—CYP3A4—bone cancer	4.27e-05	0.00292	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	4.21e-05	0.00288	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	4.15e-05	0.00284	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—NT5C3A—bone cancer	4.13e-05	0.00282	CbGpPWpGaD
Telithromycin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.69e-05	0.00252	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—GSTP1—bone cancer	3.65e-05	0.0025	CbGpPWpGaD
Telithromycin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	3.62e-05	0.00247	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	3.6e-05	0.00246	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—NDUFA12—bone cancer	3.6e-05	0.00246	CbGpPWpGaD
Telithromycin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	3.57e-05	0.00244	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.26e-05	0.00223	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.26e-05	0.00223	CbGpPWpGaD
Telithromycin—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.09e-05	0.00211	CbGpPWpGaD
Telithromycin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.05e-05	0.00208	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—NT5C3A—bone cancer	2.98e-05	0.00204	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—NDUFA12—bone cancer	2.56e-05	0.00175	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.39e-05	0.00163	CbGpPWpGaD
Telithromycin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.35e-05	0.00161	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—NDUFA12—bone cancer	2.17e-05	0.00148	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—NT5C3A—bone cancer	2.12e-05	0.00145	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—ENO2—bone cancer	1.81e-05	0.00123	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—NT5C3A—bone cancer	1.8e-05	0.00123	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—DHFR—bone cancer	1.68e-05	0.00115	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—NDUFA12—bone cancer	1.67e-05	0.00114	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GNA11—bone cancer	1.57e-05	0.00107	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000971	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—NT5C3A—bone cancer	1.39e-05	0.000947	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—ENO2—bone cancer	1.31e-05	0.000893	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GSTP1—bone cancer	1.21e-05	0.00083	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—DHFR—bone cancer	1.21e-05	0.000828	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GNA11—bone cancer	1.13e-05	0.000774	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—CYP3A4—bone cancer	1.03e-05	0.000702	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—ENO2—bone cancer	9.29e-06	0.000635	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GSTP1—bone cancer	8.78e-06	0.0006	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—DHFR—bone cancer	8.62e-06	0.000589	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GNA11—bone cancer	8.05e-06	0.00055	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—ENO2—bone cancer	7.87e-06	0.000538	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—CYP3A4—bone cancer	7.3e-06	0.000499	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—DHFR—bone cancer	7.3e-06	0.000499	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GNA11—bone cancer	6.82e-06	0.000466	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—PTGS2—bone cancer	6.29e-06	0.00043	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GSTP1—bone cancer	6.24e-06	0.000427	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—CYP3A4—bone cancer	6.19e-06	0.000423	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.15e-06	0.000421	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—ENO2—bone cancer	6.07e-06	0.000415	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—DHFR—bone cancer	5.63e-06	0.000385	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GSTP1—bone cancer	5.29e-06	0.000361	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GNA11—bone cancer	5.27e-06	0.00036	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—PTGS2—bone cancer	4.55e-06	0.000311	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GSTP1—bone cancer	4.08e-06	0.000279	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—PTGS2—bone cancer	3.24e-06	0.000221	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—PTGS2—bone cancer	2.74e-06	0.000187	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—PTGS2—bone cancer	2.12e-06	0.000145	CbGpPWpGaD
